The IgG4-related disease market is growing due to increased diagnosis rates, more awareness of disease mechanisms, and better diagnostic tools. Companies such as AstraZeneca, Horizon Therapeutics, and InflaRx are working on therapies targeting immune modulation. Rising patient demand, investments in clinical trials, and improvements in treatment protocols are pushing the market forward. Access Market Report: https://shorturl.at/DlwH2